TRANSPLANTATION OF ES CELLS-DERIVED DOPAMINERGIC NEURONS

$46,835P51FY2009RRNIH

University Of Wisconsin-Madison, Madison WI

Investigators

Linked publications & trials

Paper 39642160 Paper 38760983 Paper 38639635 Paper 38635668 Paper 38020807 Paper 37860906 Paper 37814073 Paper 37782672 Paper 37425681 Paper 37333300 Paper 37185781 Paper 37090620 Paper 36993525 Paper 36909458 Paper 36825014 Paper 36763214 Paper 36582226 Paper 36377872 Paper 35705631 Paper 35595058 Paper 35491543 Paper 35130312 Paper 33591361 Paper 33229035 Paper 33043166 Paper 32956357 Paper 32709417 Paper 32643223 Paper 32515834 Paper 32402468 Paper 32256496 Paper 32250358 Paper 32235848 Paper 32052009 Paper 31890736 Paper 31542153 Paper 31422797 Paper 31416800 Paper 31415241 Paper 31038661 Paper 31036928 Paper 30897187 Paper 30850342 Paper 30746836 Paper 30642966 Paper 30578305 Paper 30500414 Paper 30353260 Paper 30281932 Paper 30224552 Paper 29992471 Paper 29861167 Paper 29791856 Paper 29616024 Paper 29594415 Paper 29583085 Paper 29514073 Paper 29249843 Paper 29118125 Paper 28594774 Paper 28502529 Paper 28473378 Paper 28398464 Paper 28213784 Paper 28115506 Paper 28094793 Paper 27879435 Paper 27827365 Paper 27795809 Paper 27707919 Paper 27573879 Paper 27170760 Paper 27154414 Paper 27068622 Paper 27017056 Paper 26962218 Paper 26951656 Paper 26908578 Paper 26877223 Paper 26867176 Paper 26772634 Paper 26769326 Paper 26745269 Paper 26739266 Paper 26739054 Paper 26710184 Paper 26559828 Paper 26491171 Paper 26490669 Paper 26378244 Paper 26253726 Paper 26232089 Paper 26200852 Paper 26178985 Paper 26163094 Paper 26067103 Paper 26009014 Paper 25891651 Paper 25845705 Paper 25799436

Abstract

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Objective: To explore the use of human and monkey embryonic stem (ES) cells derived dopamine neurons for cell replacement therapy in Parkinson's disease. Cell replacement strategies have been proposed as a treatment for advanced Parkinson's disease. Two years ago, we began a pilot study using dopaminergic-human ES cells to assess viability and safety in the monkey brain. Last year, we analyzed the data. Our results suggest that differentiated hES cells in the monkey brain are able to elicit an immune response that affects their dopaminergic characteristics and survival. This research used Animal Services, CPI, Stem Cell Resource, and Pathology Services. Publications pending.

View original record on NIH RePORTER →